Novogenia AG (MUN:7V0)
Germany · Delayed Price · Currency is EUR 5.95
0.00 (0.00%)
Last updated: Aug 5, 2026, 8:00 AM CET
Novogenia AG Market Cap
Novogenia AG has a market cap or net worth of €71.4 million as of August 5, 2026. Its market cap has decreased by -18.49% in one year.
Market Cap
71.40M
Enterprise Value
24.53M
Revenue
54.30M
Ranking
n/a
PE Ratio
130.90
Stock Price
€5.95
ChartMarket Cap Chart
Since November 2, 2021, Novogenia AG's market cap has increased from 21.30M to 71.40M, an increase of 235.21%. That is a compound annual growth rate of 28.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 71.40M | -23.23% |
| Dec 22, 2025 | 93.00M | -14.36% |
| Dec 29, 2023 | 108.60M | -21.30% |
| Dec 30, 2022 | 138.00M | 88.52% |
| Dec 13, 2021 | 73.20M | 243.66% |
| Nov 2, 2021 | 21.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| 2invest AG | 44.63M |
| Biomark Diagnostics | 34.29M |
| Vidac Pharma Holding | 23.18M |
| co.don AG | 427.57K |
| Paion AG | 392.35K |
| bioXXmed AG | 236.52K |
| MagForce AG | 91.72K |